Cargando…
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the prognosis remains poor, and it is highly anticipated that new drugs will be developed. New drugs, such a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304407/ https://www.ncbi.nlm.nih.gov/pubmed/30479094 http://dx.doi.org/10.3802/jgo.2019.30.e10 |